2018 annual financial data
ALX Oncology Holdings 2018 Operating margin
Direct answer
Operating margin was -662.02%.
Operating income was -13,684,000 USD and net income was -13,731,000 USD.
Operating cash flow was -13,190,000 USD.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,067,000 USD
- Operating income
- -13,684,000 USD
- Net income
- -13,731,000 USD
- Operating cash flow
- -13,190,000 USD